Transfoveal Micropulse Laser Treatment of Central Serous Chorioretinopathy within Six Months of Disease Onset

Background: It has been recommended that any invasive treatment performed in patients with central serous chorioretinopathy (CSCR) not be initiated earlier than four months after disease onset due to the potential for spontaneous remission of symptoms. The goal of this study was to examine the outco...

Descripción completa

Detalles Bibliográficos
Autores principales: Gawęcki, Maciej, Jaszczuk-Maciejewska, Agnieszka, Jurska-Jaśko, Anna, Kneba, Małgorzata, Grzybowski, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780961/
https://www.ncbi.nlm.nih.gov/pubmed/31500100
http://dx.doi.org/10.3390/jcm8091398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780961/
https://www.ncbi.nlm.nih.gov/pubmed/31500100
http://dx.doi.org/10.3390/jcm8091398

Ejemplares similares